Literature DB >> 20819287

Stability indicating LC method for the simultaneous determination of amlodipine and olmesartan in dosage form.

K R Patil1, V P Rane, J N Sangshetti, R D Yeole, D B Shinde.   

Abstract

A simple, rapid, and precise method is developed for the quantitative simultaneous estimation of amlodipine (AM) and olmesartan (OL) in combined pharmaceutical dosage form. A chromatographic separation of the two drugs was achieved with an ACE 5 C(18) 25-cm analytical column using buffer-acetonitrile (60:40, v/v). The resolution between OL and AM was found to be more than 12. Theoretical plates for OL and AM were 6970 and 11,841, respectively. Tailing factor for OL and AM was 0.90 and 0.98, respectively. OL, AM, and combination drug product were exposed to thermal, photolytic, hydrolytic, and oxidative stress conditions, and the stressed samples were analyzed by the proposed method. Peak homogeneity data of OL and AM is obtained by photodiode array detector in the stressed sample chromatograms, demonstrating the specificity of the method for their estimation in presence of degradation product. The described method shows excellent linearity over a range of 20-400 microg/mL for OL and 5-100 microg/mL for AM. The correlation coefficient for OL and AM are 0.9995 and 0.9998, respectively. The relative standard deviation for six measurements in two sets of each drug in tablets is always less than 2%. The proposed method was found to be suitable and accurate for quantitative determination and stability study of OL and AM in pharmaceutical preparations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819287     DOI: 10.1093/chromsci/48.7.601

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  5 in total

1.  Multivariate versus classical univariate calibration methods for spectrofluorimetric data: application to simultaneous determination of olmesartan medoxamil and amlodipine besylate in their combined dosage form.

Authors:  Hany W Darwish; Ahmed H Backeit
Journal:  J Fluoresc       Date:  2012-08-16       Impact factor: 2.217

2.  Development and Validation of highly Sensitive Stability Indicating Spectrofluorimetric Method for Determination of Amlodipine in Pharmaceutical Preparations and Human Plasma.

Authors:  Abdel-Maaboud I Mohamed; Mahmoud A Omar; Mohamed A Hammad; Abobakr A Mohamed
Journal:  J Fluoresc       Date:  2016-08-26       Impact factor: 2.217

3.  LC, MS n and LC-MS/MS studies for the characterization of degradation products of amlodipine.

Authors:  Ravi N Tiwari; Nishit Shah; Vikas Bhalani; Anand Mahajan
Journal:  J Pharm Anal       Date:  2014-08-07

4.  Central Composite Design for Validation of HPTLC Method for Simultaneous Estimation of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Tablets.

Authors:  Trupti B Solanki; Purvi A Shah; Kalpana G Patel
Journal:  Indian J Pharm Sci       Date:  2014-05       Impact factor: 0.975

5.  Development and Validation of a Chromatography Method Using Tandem UV/Charged Aerosol Detector for Simultaneous Determination of Amlodipine Besylate and Olmesartan Medoxomil: Application to Drug-Excipient Compatibility Study.

Authors:  Ariadne M Brondi; Jerusa S Garcia; Marcello G Trevisan
Journal:  J Anal Methods Chem       Date:  2017-12-17       Impact factor: 2.193

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.